Article info
PDFA difficult case
Lupus myelopathy
- Correspondence to Dominika D Raciborska, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 1BB, UK; nika.raciborska{at}gmail.com
Citation
Lupus myelopathy
Publication history
- Accepted October 15, 2017
- First published November 2, 2017.
Online issue publication
April 19, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Other content recommended for you
- Autologous stem cell transplantation in a case of treatment resistant central nervous system lupus
- THE DIFFERENTIAL DIAGNOSIS OF MULTIPLE SCLEROSIS
- Demyelination in rheumatic diseases
- EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs
- Belimumab in systemic lupus erythematosus
- PO.1.12 Transcriptome profiling and autoimmunity-related serological markers identify TP53 and C3aR as drug targets in neuropsychiatric systemic lupus erythematosus
- Angioedema as the presenting feature of systemic lupus erythematosus
- Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET
- Retinal disease in patients with systemic lupus erythematosus
- Intermittent and Persistent Type 2 lupus: patient perspectives on two distinct patterns of Type 2 SLE symptoms